GME — Geratherm Medical AG Income Statement
0.000.00%
- €17.48m
- €10.92m
- €13.98m
- 68
- 63
- 12
- 42
Annual income statement for Geratherm Medical AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27.5 | 23.9 | 25.9 | 21 | 14 |
Cost of Revenue | |||||
Gross Profit | 17.6 | 16.3 | 16.3 | 16.5 | 6.34 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24.4 | 23.4 | 23.9 | 18.6 | 13 |
Operating Profit | 3.04 | 0.49 | 1.91 | 2.36 | 0.955 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.72 | 0.308 | 1.73 | 2.32 | 0.982 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.9 | 0.333 | 1.08 | 1.67 | 0.654 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.05 | 0.122 | 1.02 | 1.11 | 0.705 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.05 | 0.122 | 1.02 | 1.11 | 0.705 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.413 | 0.128 | 0.274 | 0.278 | 0.205 |
Dividends per Share |